MedTrace Logo

Efficacy of an Attentional Process Training Using Competitive Versus Non Competitive Strategies

NCT02220816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-08-19

No results posted yet for this study

Summary

Within a prospective, randomised, controlled study 60, selected patients with chronic (\> 6 months) stroke or traumatic brain injury will be randomised to 30 1-hour sessions of competitive versus non-competitive attentional training. Competitive training will include fifteen 1-hour sessions of standard (paper and pencil) training under competitive situations and fifteen 1-hour sessions of competitive attentional games designed for this purpose using a new virtual reality system (conventional liquid-crystal-display screen with an infrared LED array to facilitate multi-touch experience embedded in a conventional table). Progress will be evaluated by pre and post measurement of attentional neuropsychological tests, subjective reports of global attention, usability and motivational scales. Our hypothesis is that competitive training is more effective in improving attention than conventional training in the chronic phase after acquired brain injury.

Conditions

Interventions

BEHAVIORAL

Competitive training

30 sessions of competitive cognitive training; 3 - 5 sessions/week; duration 45 min

BEHAVIORAL

Non-Competitive Training

30 sessions of non-competitive cognitive training; 3 - 5 sessions/week; duration 45 min

Sponsors & Collaborators

  • Universitat Politècnica de València

    collaborator OTHER

  • University of Seville

    collaborator OTHER

  • Hospitales Nisa

    lead OTHER

Principal Investigators

  • Roberto Llorens, PhD · Universitat Politècnica de València

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220816 on ClinicalTrials.gov